A new twice-monthly publication dedicated to IVD, In Vitro Diagnostics Business Outlook offers the following:
• Market Sizing and Forecasting of IVD Market Segments in Every Issue • Clinical Chemistry, Infectious Disease Testing, Oncology, Hematology, Blood Banking, Coagulation, Point of Care–Updates on the Important Test Categories You Need to Know About • Industry Watch – Developments with COVID-19 and Other Testing • M&A, Distribution, Partnerships Tracked and Charted • New Product Introductions and Company Announcements • Company Profiling and Quarterly Results Summaries • Regional Market Coverage
Page Count: 47
Table of Contents
Untitled Chapter
Market Analysis
Overview of IVD Influenza Testing
Market Outlook
Major Product Activity
Company Briefs
Thermo Fisher
Roche
Siemens Healthineers
Regional Market
Executive News Briefing
Briefs
Osler Diagnostics Raises $85 Million
Hologic Awarded $19 Million BARDA Contract
Navignostics Secures Investment of CHF 7.5 million
Biocartis Reports Q3 Product Revenue up 14% in 2022 Lead by Oncology Cartridge Demand
Haemonetics Corporation Reported 24% Year-over-Year Growth in Second Quarter FY23
Siemens Finishes Strong; Reports Fiscal Year 2022 Growth in All Segments
Diagnostic Market Mergers, Acquisitions and Partnership Deals
Mergers and Acquisitions
Selected Partnerships and Collaborations
Industry Watch
Virus Testing Update
Region Watch
Ireland
Slovenia
United Arab Emirates
Broad-based Company Announcements
Announcements
Cepheid Garnered CE Mark for Xpert Xpress GBS
DiaSorin Announces New FDA Clearance
Siemens Healthineers to Restructure Diagnostics Division